Robin Medical Limited Company accounts

COMPANY REGISTRATION NUMBER: 4613869

Robin Medical Limited

Unaudited Financial Statements

31 December 2025

Robin Medical Limited

Financial Statements

Year ended 31 December 2025

Contents	Pages

Officers and professional advisers	1

Director's report	2

Statement of income and retained earnings	3

Statement of financial position	4

Notes to the financial statements	5 to 7

The following pages do not form part of the financial statements

Chartered certified accountants report to the director on the preparation of the unaudited statutory financial statements	9

Robin Medical Limited

Officers and Professional Advisers

Director	Mr. M.R. Alkhatib

Company secretary	Mrs. N. B.Hamdan

Registered office	26 A, Breakfield
	Ullswater Industrial Estate
	Coulsdon
	Surrey
	CR5 2HS

Accountants	Begg, Williamson & Co
	Chartered Certified Accountants
	24 Church Road
	Crystal Palace
	London
	UK
	SE19 2ET

Robin Medical Limited

Director's Report

Year ended 31 December 2025

The director presents his report and the unaudited financial statements of the company for the year ended 31 December 2025 .

Director

The director who served the company during the year was as follows:

Mr. M.R. Alkhatib

Small company provisions

This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.

This report was approved by the board of directors on 8 September 2026 and signed on behalf of the board by:

Mr. M.R. Alkhatib	Mrs. N. B.Hamdan
Director	Company Secretary

Registered office:

26 A, Breakfield

Ullswater Industrial Estate

Coulsdon

Surrey

CR5 2HS

Robin Medical Limited

Statement of Income and Retained Earnings

Year ended 31 December 2025

	2025	2024
Note	£	£
Turnover	117,385	132,359

Cost of sales	45,010	51,523
	---------	---------
Gross profit	72,375	80,836

Administrative expenses	79,354	75,947
	--------	--------
Operating (loss)/profit	( 6,979)	4,889

	--------	--------
(Loss)/profit before taxation	( 6,979)	4,889

Tax on (loss)/profit	–	–
	-------	-------
(Loss)/profit for the financial year and total comprehensive income	( 6,979)	4,889
	-------	-------

Dividends paid and payable	–	( 10,000)

Retained earnings at the start of the year	6,318	11,429
	-------	--------
Retained (losses)/earnings at the end of the year	( 661)	6,318
	-------	--------

All the activities of the company are from continuing operations.

Robin Medical Limited

Statement of Financial Position

31 December 2025

	2025		2024
Note	£	£	£

Fixed assets

Tangible assets	5		2	2

Current assets

Stocks		4,500	5,000
Debtors	6	1,025	–
Cash at bank and in hand		685	7,395
		-------	--------
		6,210	12,395

Creditors: amounts falling due within one year	7	5,873		5,079
		-------		--------
Net current assets			337	7,316
			----	-------
Total assets less current liabilities			339	7,318
			----	-------

Capital and reserves

Called up share capital	1,000	1,000
Profit and loss account	( 661)	6,318
	-------	-------
Shareholders funds	339	7,318
	-------	-------

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

For the year ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;

- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .

These financial statements were approved by the board of directors and authorised for issue on 8 September 2026 , and are signed on behalf of the board by:

Mr. M.R. Alkhatib
Director

Company registration number: 4613869

Robin Medical Limited

Notes to the Financial Statements

Year ended 31 December 2025

1. General information

The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 26 A, Breakfield, Ullswater Industrial Estate, Coulsdon, Surrey, CR5 2HS.

2. Statement of compliance

These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.

3. Accounting policies

Basis of preparation

The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

The financial statements are prepared in sterling, which is the functional currency of the entity.

Revenue recognition

Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

Tangible assets

Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.

Depreciation

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

Fixture, Fittings & Equip	-	25% straight line
fixture, fittings & equipment	-	25% straight line

Impairment of fixed assets

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.

Stocks

Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stock to its present location and condition.

Financial instruments

Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

4. Employee numbers

The average number of persons employed by the company during the year amounted to 4 (2024: 4 ).

5. Tangible assets

	Fixtures and fittings	Equipment	Total
	£	£	£
Cost
At 1 January 2025 and 31 December 2025	2,125	4,863	6,988
	-------	-------	-------
Depreciation
At 1 January 2025 and 31 December 2025	2,124	4,862	6,986
	-------	-------	-------
Carrying amount
At 31 December 2025	1	1	2
	-------	-------	-------
At 31 December 2024	1	1	2
	-------	-------	-------

6. Debtors

	2025	2024
	£	£
Other debtors	1,025	–
	-------	----

7. Creditors: amounts falling due within one year

	2025	2024
	£	£
Social security and other taxes	–	3,890
Other creditors	5,873	1,189
	-------	-------
	5,873	5,079
	-------	-------

8. Director's advances, credits and guarantees

During the year the director entered into the following advances and credits with the company:

	2025
	Balance brought forward	Advances/ (credits) to the director	Balance outstanding
	£	£	£
Mr. M.R. Alkhatib	( 1,189)	( 1,714)	( 2,903)
	-------	-------	-------

	2024
	Balance brought forward	Advances/ (credits) to the director	Balance outstanding
	£	£	£
Mr. M.R. Alkhatib	( 1,061)	( 128)	( 1,189)
	-------	----	-------

9. Related party transactions

The company was under the control of Mr M.Alkhatib and Mrs.N. Hamdan throughout the current and previous year. Mr M. Alkhatib holds 50% of the issued share capital and Mrs. Hamdan holds the remaining 50% of the share capital. No transactions with related parties were undertaken such as are required to be disclosed under FRSSE.

Robin Medical Limited

Management Information

Year ended 31 December 2025

The following pages do not form part of the financial statements.

Robin Medical Limited

Chartered Certified Accountants Report to the Director on the Preparation of the Unaudited Statutory Financial Statements of Robin Medical Limited

Year ended 31 December 2025

As described on the statement of financial position, the director of the company is responsible for the preparation of the financial statements for the year ended 31 December 2025, which comprise the statement of income and retained earnings, statement of financial position and the related notes. You consider that the company is exempt from an audit under the Companies Act 2006. In accordance with your instructions we have compiled these financial statements in order to assist you to fulfil your statutory responsibilities, from the accounting records and from information and explanations supplied to us.

Begg, Williamson & Co Chartered Certified Accountants

24 Church Road Crystal Palace London UK SE19 2ET

8 September 2026